134 related articles for article (PubMed ID: 9772874)
1. Zonal variation of apoptosis and proliferation in the normal prostate and in benign prostatic hyperplasia.
Colombel M; Vacherot F; Diez SG; Fontaine E; Buttyan R; Chopin D
Br J Urol; 1998 Sep; 82(3):380-5. PubMed ID: 9772874
[TBL] [Abstract][Full Text] [Related]
2. [Cell apoptosis and proliferation in the transition and peripheral zones in human prostate].
Sun HB; Xia SJ
Zhonghua Nan Ke Xue; 2007 Feb; 13(2):110-3. PubMed ID: 17345763
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic versus proliferative activities in human benign prostatic hyperplasia.
Kyprianou N; Tu H; Jacobs SC
Hum Pathol; 1996 Jul; 27(7):668-75. PubMed ID: 8698310
[TBL] [Abstract][Full Text] [Related]
4. Basal cell hyperplasia in the peripheral zone of the prostate.
Thorson P; Swanson PE; Vollmer RT; Humphrey PA
Mod Pathol; 2003 Jun; 16(6):598-606. PubMed ID: 12808066
[TBL] [Abstract][Full Text] [Related]
5. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins.
Tang DG; Li L; Chopra DP; Porter AT
Cancer Res; 1998 Aug; 58(15):3466-79. PubMed ID: 9699682
[TBL] [Abstract][Full Text] [Related]
6. Does benign prostatic hyperplasia originate from the peripheral zone of the prostate? A preliminary study.
Tang J; Yang JC; Zhang Y; Liu X; Zhang L; Wang Z; Li J; Luo Y; Xu J; Shi H
BJU Int; 2007 Nov; 100(5):1091-6. PubMed ID: 17922787
[TBL] [Abstract][Full Text] [Related]
7. Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium.
Wang W; Bergh A; Damber JE
Prostate; 2004 Sep; 61(1):60-72. PubMed ID: 15287094
[TBL] [Abstract][Full Text] [Related]
8. Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer.
Häussler O; Epstein JI; Amin MB; Heitz PU; Hailemariam S
Hum Pathol; 1999 Sep; 30(9):1077-86. PubMed ID: 10492043
[TBL] [Abstract][Full Text] [Related]
9. Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.
Shariat SF; Ashfaq R; Roehrborn CG; Slawin KM; Lotan Y
J Urol; 2005 Nov; 174(5):2046-50. PubMed ID: 16217391
[TBL] [Abstract][Full Text] [Related]
10. Resistance to apoptosis and up regulation of Bcl-2 in benign prostatic hyperplasia after androgen deprivation.
Cardillo M; Berchem G; Tarkington MA; Krajewski S; Krajewski M; Reed JC; Tehan T; Ortega L; Lage J; Gelmann EP
J Urol; 1997 Jul; 158(1):212-6. PubMed ID: 9186362
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis profiles in benign prostatic hyperplasia: close associations of cell kinetics with percent area density of histologic composition.
Zhang X; Zhang Q; Zhang Z; Na Y; Guo Y
Urology; 2006 Oct; 68(4):905-10. PubMed ID: 17070390
[TBL] [Abstract][Full Text] [Related]
12. IMPORTANCE OF APOPTOSIS MARKERS (MDM2, BCL-2 AND Bax) IN BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER.
Saker Z; Tsintsadze O; Jiqia I; Managadze L; Chkhotua A
Georgian Med News; 2015 Dec; (249):7-14. PubMed ID: 26719543
[TBL] [Abstract][Full Text] [Related]
13. Prostatic neuroendocrine cells have a unique keratin expression pattern and do not express Bcl-2: cell kinetic features of neuroendocrine cells in the human prostate.
Xue Y; Verhofstad A; Lange W; Smedts F; Debruyne F; de la Rosette J; Schalken J
Am J Pathol; 1997 Dec; 151(6):1759-65. PubMed ID: 9403726
[TBL] [Abstract][Full Text] [Related]
14. Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: differences between tumours located in the transition zone and in the peripheral zone.
Erbersdobler A; Fritz H; Schnöger S; Graefen M; Hammerer P; Huland H; Henke RP
Eur Urol; 2002 Jan; 41(1):40-6. PubMed ID: 11999464
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis-related gene expression in benign prostatic hyperplasia and prostate carcinoma.
Iacopino F; Angelucci C; Lama G; Zelano G; La Torre G; D'Addessi A; Giovannini C; Bertaccini A; Macaluso MP; Martorana G; Sica G
Anticancer Res; 2006; 26(3A):1849-54. PubMed ID: 16827116
[TBL] [Abstract][Full Text] [Related]
16. Relation between Bcl-2, cell proliferation, and the androgen receptor status in prostate tissue and precursors of prostate cancer.
Bonkhoff H; Fixemer T; Remberger K
Prostate; 1998 Mar; 34(4):251-8. PubMed ID: 9496899
[TBL] [Abstract][Full Text] [Related]
17. Distribution of chronic prostatitis in radical prostatectomy specimens with up-regulation of bcl-2 in areas of inflammation.
Gerstenbluth RE; Seftel AD; MacLennan GT; Rao RN; Corty EW; Ferguson K; Resnick MI
J Urol; 2002 May; 167(5):2267-70. PubMed ID: 11956490
[TBL] [Abstract][Full Text] [Related]
18. Incidence of apoptosis and cell proliferation in prostate cancer: relationship with TGF-beta1 and bcl-2 expression.
Tu H; Jacobs SC; Borkowski A; Kyprianou N
Int J Cancer; 1996 Oct; 69(5):357-63. PubMed ID: 8900367
[TBL] [Abstract][Full Text] [Related]
19. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
[TBL] [Abstract][Full Text] [Related]
20. Effects of tomato sauce consumption on apoptotic cell death in prostate benign hyperplasia and carcinoma.
Kim HS; Bowen P; Chen L; Duncan C; Ghosh L; Sharifi R; Christov K
Nutr Cancer; 2003; 47(1):40-7. PubMed ID: 14769536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
